Subscribe
This UK income stalwart had a successful 2025. We take a deep dive into its portfolio and ask: can it do it again?
Portfolio Clinic: Our reader wants to retire early, but sold up at the worst time. Val Cipriani looks at what to do next
Analysts think poor performance for the likes of Terry Smith and Nick Train has little chance of reversing in the near future
Some fund managers try to avoid thinking of benchmarks, but are they trying to hide away, Val Cipriani asks?
A new CEO could change the fortunes of this unloved stock, says Temple Bar’s Ian Lance
Listed infrastructure funds offer protection from inflation and some income on top
Pershing Square now has a sizeable exposure to US tech giants
Portfolio Clinic: Our readers want to be financially independent. Val Cipriani looks at how to invest their sizeable pot
Managers are looking at South Korea, Brazil and South Africa
This company’s complexity puts investors off, but there’s plenty to like, says Odyssean’s Stuart Widdowson